Astal Laboratories Ltd — Important, 14-08-2026: Company Update

Astal Laboratories has announced the utilization status of funds raised from three preferential allotments for the quarter ended June 30, 2026. The company confirmed no deviation in the use of these funds. From the first allotment, 3.06 Cr was fully utilized for long-term needs, capital expenditure, and working capital. The second allotment of 4.41 Cr was also fully deployed for similar purposes. For the third allotment of 0.34 Cr, 0.09 Cr has been utilized for these growth objectives, with the company reaffirming no deviation.